‹ All stocks

Cardio Diagnostics Holdings

CDIO · NASDAQ · Healthcare

$2.01

▲ $2.01 (1.52%)

1D 7D 1M 3M 1Y All

Day range

$1.98 – $2.03

Year range

$0.97 – $7.91

Open

$1.98

Previous close

—

Market cap

$5.95M

Volume (24h)

$3.7K

Volume (52w)

$7.49K

Performance

▲ 6.35%

▲ 2.55%

▲ 5.24%

▼ -0.99%

▼ -54.21%

YTD

▼ -29.23%

▼ -78.71%

▼ -99.32%

All-time

▼ -99.32%

Key statistics

P/E ratio

-0.69

EPS (TTM)

$-2.92

Dividend yield

—

Dividend (TTM)

—

Payout ratio

—

Shares outstanding

3.0M

About Cardio Diagnostics Holdings

Founded in Chicago, Illinois, in 2017, Cardio Diagnostics Holdings, Inc. specializes in the creation and market introduction of clinical tests. These diagnostic tools leverage epigenetics to assess cardiovascular disease risk. Among its offerings is Epi+Gen CHD, a test designed to predict the risk of symptomatic coronary heart disease over a three-year timeframe.

Visit website

Country: United States of America

LLY Eli Lilly and Company	$1143.12	-0.59%
JNJ Johnson & Johnson	$252.93	-2.22%
ABBV AbbVie	$265.76	2.20%
MRK Merck & Co.	$139.54	-2.97%
UNH UnitedHealth Group Incorp…	$378.58	3.66%